1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas
- 24 February 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 32 (4), 866-885
- https://doi.org/10.1681/asn.2020060832
Abstract
Background Few therapies prevent venous neointimal hyperplasia (VNH) and venous stenosis (VS) formation in arteriovenous fistulas (AVF). Expression of the immediate early response gene X-1 (Iex-1), also known as Ier3, is associated with VNH and stenosis in murine AVFs. The study aimed to determine if local release of Ier3 long-acting inhibitor 1α,25(OH)2D3 from poly(lactic-co-glycolic acid) (PLGA) nanoparticles embedded in a thermosensitive Pluronic F127 hydrogel (1,25 NP) could affect VNH/VS formation in a large animal model. Methods Immediately after AVF creation in a porcine model of renal failure, 1,25 NP or vehicle control was injected into the adventitia space of AVF outflow veins. Scanning electron microscopy and dynamic light scattering characterized drug and control nanoparticles. Animals were sacrificed 3 and 28 days later for gene expression, immunohistologic, magnetic resonance imaging and angiography, and ultrasound analyses. Whole transcriptome RNA sequencing with differential gene expression analysis was performed on outflow veins of AVF. Results Encapsulation of 1α,25(OH)2D3 in PLGA nanoparticles formed nanoparticles of uniform size that were similar to nanoparticles without 1α,25(OH)2D3. The 1,25 NP–treated AVFs exhibited lower VNH/VS, Ier3 gene expression, and IER-3, MCP-1, CD68, HIF-1α, and VEGF-A immunostaining, fibrosis, and proliferation. Blood flow and lumen area increased significantly, whereas peak systolic velocity and wall shear stress decreased. Treatment increased Young’s modulus and correlated with histologic assessment of fibrosis and with no evidence of vascular calcification. RNA sequencing analysis showed changes in the expression of genes associated with inflammatory, TGFβ1, and apoptotic pathways. Conclusions Local release of 1,25 NP improves AVF flow and hemodynamics, and reduces stenosis in association with reduction in inflammation, apoptosis, and fibrosis in a porcine model of arteriovenous fistula.Keywords
Funding Information
- NIH (HL098967, DK107870)
- NIH (R01 49039)
This publication has 60 references indexed in Scilit:
- Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access modelKidney International, 2013
- Quantification of 1α,25-Dihydroxy Vitamin D by Immunoextraction and Liquid Chromatography–Tandem Mass SpectrometryClinical Chemistry, 2011
- Increased Expression of HIF-1α, VEGF-A and Its Receptors, MMP-2, TIMP-1, and ADAMTS-1 at the Venous Stenosis of Arteriovenous Fistula in a Mouse Model with Renal InsufficiencyJournal of Vascular and Interventional Radiology, 2010
- Hypoxia-induced Phenotypic Switch of Fibroblasts to Myofibroblasts through a Matrix Metalloproteinase 2/Tissue Inhibitor of Metalloproteinase–mediated Pathway: Implications for Venous Neointimal Hyperplasia in Hemodialysis AccessJournal of Vascular and Interventional Radiology, 2010
- Wall Shear Stress Measurement Using Phase Contrast Magnetic Resonance Imaging with Phase Contrast Magnetic Resonance Angiography in Arteriovenous Polytetrafluoroethylene GraftsAngiology, 2009
- Hemodynamic wall shear stress profiles influence the magnitude and pattern of stenosis in a pig AV fistulaKidney International, 2008
- Venous stenosis in a pig arteriovenous fistula model--anatomy, mechanisms and cellular phenotypesNephrology Dialysis Transplantation, 2007
- A Novel Immediate Early Response Gene, IEX-1, Is Induced by Ultraviolet Radiation in Human KeratinocytesBiochemical and Biophysical Research Communications, 1998
- Regulation of a Novel Immediate Early Response Gene,IEX-1,in Keratinocytes by 1α,25-Dihydroxyvitamin D3Biochemical and Biophysical Research Communications, 1998
- 1α,25-Dihydroxyvitamin D3Inhibits Normal Human Keratinocyte Growth by Increasing Transforming Growth Factor β2 ReleaseBiochemical and Biophysical Research Communications, 1996